Financial and Tax Consultant

Chief Financial Officer and/or Tax Director of five clients corporate groups, focusing primarily on merger and acquisition analyses in addition to preparation of all federal and state tax returns and monthly financial statements

Responsible for financial statement reporting of income tax provision and income tax risk assessment

Performed review of said target company’s US tax filings, generating $4M of additional federal tax credits

Reviewed prior year tax filings of publicly-traded firm, changing the approach to reporting cross border inter-company transactions, thereby saving over $7M of federal taxes.

Structured inbound acquisition using a preferred stock repurchase structure to generate a 35% tax rate arbitrage on remitted earnings

Restructured Australian acquisition by changing the Letter of Intent, saving over $1.4M of federal and state taxes

Identified economic benefits for a client using insurance products in compensatory arrangements, saving the client $800k

Extensive tax provision experience

Preparation of integrated orphan drug and R&D tax credit studies, including review of existing tax credits claimed, resulting in substantial tax credit increases for clients, varying from 5 to 7 digits in magnitude

Focus on international transfer pricing and merger and acquisition analyses, including preparation of IRC Section 382 studies for venture capital funded pharmaceutical targets

Performed economic functional analysis for an international pharmaceuticals company, implemented transfer pricing recommendations to reduce domestic operating margin from 29% to 8%, thereby generating initial worldwide tax savings of $27M while reducing audit exposure.

Structured cross border acquisition of pharmaceuticals company, minimizing the post-acquisition federal and state tax burden through a leveraged acquisition structure, achieving a 25% tax rate arbitrage

Analyzed multinational pharmaceutical company’s US distribution subsidiary’s federal and state tax returns, amending same achieving over $1.5M of tax savings and eliminating state tax nexus exposure